Home / Japan / Perseus Proteomics Inc.
Perseus Proteomics Inc.
Short position disclosed on October 21, 2026.
0.79% of the capital sold short
1 disclosing fund
56 disclosures on record
Evolution of the disclosed total
0%1%2%3%4%
Aug 19Sep 4Sep 20Oct 6Oct 22
Open positions
| Fund | Twelve months | % of capital | Over the year | Since |
|---|---|---|---|---|
| Barclays Capital Securities Ltd | 0.79% | -1.94 pt | October 21, 2026 |
Get the moves on Perseus Proteomics Inc. by mail, at most once a day.
There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| August 7, 2026 | Nomura International plc | 0.71% | |
| August 6, 2026 | Nomura International plc | 0.67% | |
| August 5, 2026 | Barclays Capital Securities Ltd | 2.44% | |
| August 4, 2026 | Barclays Capital Securities Ltd | 2.57% | |
| August 3, 2026 | Barclays Capital Securities Ltd | 2.73% | |
| August 3, 2026 | Nomura International plc | 0.78% |
Download 56 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats
Other companies sold short in Japan
- Towa Corporation 15.37% of the capital sold short
- W-SCOPE Corporation 12.83% of the capital sold short
- INTERTRADE Co.,Ltd. 12.77% of the capital sold short
- ReYuu Japan Inc. 12.25% of the capital sold short
- Datasection Inc. 12.03% of the capital sold short
- KLab Inc. 10.87% of the capital sold short
- SHIFT Inc. 9.60% of the capital sold short
- QD Laser,Inc. 8.44% of the capital sold short
- ERTH Group Co.,Ltd. 8.08% of the capital sold short
- Toyo Engineering Corporation 7.57% of the capital sold short
- Nissan Motor Co.,ltd. 7.40% of the capital sold short
- Dynamic Map Platform Co.,Ltd. 6.92% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Perseus Proteomics Inc., source JPX, data as at October 21, 2026, https://www.quivad.com/action/perseus-proteomics-inc?page=2